Your browser doesn't support javascript.
loading
Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial.
Stöhr, Robert; Brandenburg, Vincent M; Heine, Gunnar H; Maeder, Micha T; Leibundgut, Gregor; Schuh, Alexander; Jeker, Urs; Pfisterer, Matthias; Sanders-van Wijk, Sandra; Brunner-la Rocca, Hans-Peter.
Afiliação
  • Stöhr R; Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Germany.
  • Brandenburg VM; Department of Cardiology and Nephrology, Rhein-Maas Klinikum, Würselen, Germany.
  • Heine GH; AGAPLESION MARKUS KRANKENHAUS, Frankfurt am Main, Germany.
  • Maeder MT; Department of Cardiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Leibundgut G; Department of Internal Medicine, Cardiology, Kantonsspital Baselland, Liestal, Switzerland.
  • Schuh A; Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Germany.
  • Jeker U; Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland.
  • Pfisterer M; Department of Cardiology, University Hospital Basel, Basel, Switzerland.
  • Sanders-van Wijk S; Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Brunner-la Rocca HP; Department of Cardiology, University Hospital Basel, Basel, Switzerland.
Eur J Heart Fail ; 22(4): 701-709, 2020 04.
Article em En | MEDLINE | ID: mdl-32020782

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article